Show simple item record

dc.contributor.authorManning, Victoria
dc.contributor.authorGarfield, Joshua BB
dc.contributor.authorBest, David
dc.contributor.authorBerends, Lynda
dc.contributor.authorRoom, Robin
dc.contributor.authorMugavin, Janette
dc.contributor.authorLarner, Andrew
dc.contributor.authorLam, Tina
dc.contributor.authorBuykx, Penny
dc.contributor.authorAllsop, Steve
dc.contributor.authorLubman, Dan I
dc.date.accessioned2020-11-06T17:42:16Z
dc.date.available2020-11-06T17:42:16Z
dc.date.issued2016-01-14
dc.identifier.citationManning, V., Garfield, J.B., Best, D., Berends, L., Room, R., Mugavin, J., Larner, A., Lam, T., Buykx, P., Allsop, S. and Lubman, D.I., (2017). 'Substance use outcomes following treatment: findings from the Australian Patient Pathways Study'. Australian & New Zealand Journal of Psychiatry, 51(2), pp.1 77-189.en_US
dc.identifier.doi10.1177/0004867415625815
dc.identifier.urihttp://hdl.handle.net/10545/625362
dc.description.abstractOur understanding of patient pathways through specialist Alcohol and Other Drug treatment and broader health/welfare systems in Australia remains limited. This study examines how treatment outcomes are influenced by continuity in specialist Alcohol and Other Drug treatment, engagement with community services and mutual aid, and explores differences between clients who present with a primary alcohol problem relative to those presenting with a primary drug issue. In a prospective, multi-site treatment outcome study, 796 clients from 21 Alcohol and Other Drug services in Victoria and Western Australia completed a baseline interview between January 2012 and January 2013. A total of 555 (70%) completed a follow-up assessment of subsequent service use and Alcohol and Other Drug use outcomes 12-months later. Just over half of the participants (52.0%) showed reliable reductions in use of, or abstinence from, their primary drug of concern. This was highest among clients with meth/amphetamine (66%) as their primary drug of concern and lowest among clients with alcohol as their primary drug of concern (47%), with 31% achieving abstinence from all drugs of concern. Continuity of specialist Alcohol and Other Drug care was associated with higher rates of abstinence than fragmented Alcohol and Other Drug care. Different predictors of treatment success emerged for clients with a primary drug problem as compared to those with a primary alcohol problem; mutual aid attendance (odds ratio = 2.5) and community service engagement (odds ratio = 2.0) for clients with alcohol as the primary drug of concern, and completion of the index treatment (odds ratio = 2.8) and continuity in Alcohol and Other Drug care (odds ratio = 1.8) when drugs were the primary drugs of concern. This is the first multi-site Australian study to include treatment outcomes for alcohol and cannabis users, who represent 70% of treatment seekers in Alcohol and Other Drug services. Results suggest a substantial proportion of clients respond positively to treatment, but that clients with alcohol as their primary drug problem may require different treatment pathways, compared to those with illicit drug issues, to maximise outcomes.en_US
dc.description.sponsorshipN/Aen_US
dc.language.isoenen_US
dc.publisherSAGE Publicationsen_US
dc.relation.urlhttps://journals.sagepub.com/doi/abs/10.1177/0004867415625815en_US
dc.relation.urlhttp://shura.shu.ac.uk/id/eprint/11496en_US
dc.rights.urihttp://journals.sagepub.com/page/policies/text-and-data-mining-license
dc.subjectAlcohol, drug, treatment outcomes, substance dependence, mutual aid, continuity of careen_US
dc.titleSubstance use outcomes following treatment: Findings from the Australian Patient Pathways Studyen_US
dc.typeArticleen_US
dc.identifier.eissn1440-1614
dc.contributor.departmentEastern Health, Fitzroy, VIC, Australiaen_US
dc.contributor.departmentMonash University, Melbourne, VIC, Australiaen_US
dc.contributor.departmentSheffield Hallam Universityen_US
dc.contributor.departmentAustralian Catholic University, Melbourne, VIC, Australiaen_US
dc.contributor.departmentLa Trobe University, Melbourne, VIC, Australiaen_US
dc.contributor.departmentStockholm Universityen_US
dc.contributor.departmentCurtin University, Perth, WA, Australiaen_US
dc.contributor.departmentUniversity of Sheffielden_US
dc.identifier.journalAustralian & New Zealand Journal of Psychiatryen_US
dc.identifier.pii10.1177/0004867415625815
dc.source.journaltitleAustralian & New Zealand Journal of Psychiatry
dc.source.volume51
dc.source.issue2
dc.source.beginpage177
dc.source.endpage189
dcterms.dateAccepted2016
dc.author.detail786975en_US


This item appears in the following Collection(s)

Show simple item record